Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Novartis not licensing Idenix's hepatitis C drug
Yahoo/AP
Friday, October 30, 2009 - 9:59am
tags:
Novartis, Idenix, hepatitis C
Biotech Mailbag: The Reason(s) for This Selloff
TheStreet.com
Friday, October 30, 2009 - 9:57am
tags:
biotech, selloff, Gilead Sciences, Vertex Pharmaceuticals, BioDelivery Sciences, Human Genome Sciences, Oncothyreon, Immunogen
China launches biotech VCs, new tech stock market
Fierce Biotech
Friday, October 30, 2009 - 9:56am
tags:
China
Human Genome Faces Binary Event
Minyanville
Friday, October 30, 2009 - 9:54am
tags:
Human Genome
Biopharma Deals of the Week
InVivo
Friday, October 30, 2009 - 9:23am
tags:
Sanofi, Micromet, Cephalon, BioAssets, GSK, Supergen, Astellas, Medivation
Simcere Gains Majority Control of Vaccine Subsidiary
Seeking Alpha
Friday, October 30, 2009 - 9:22am
tags:
vaccines, Simcere
Pfizer, Then and Now: Shareholder Say On Executive Pay
WSJ Online
Friday, October 30, 2009 - 9:21am
tags:
Pfizer, executive pay, shareholders
AstraZeneca Pays Millions to Settle Seroquel Cases
NY Times, NY
Friday, October 30, 2009 - 9:18am
tags:
AstraZeneca, Seroquel, settlements, whistleblowers
Shorts Using Any Bad News They Can to Drive Spectrum Pharma Down
Seeking Alpha
Friday, October 30, 2009 - 9:05am
tags:
Spectrum Pharmaceuticals
Sanofi-Aventis net profit up 6%, raises guidance
Marketwatch
Friday, October 30, 2009 - 6:51am
tags:
Sanofi, earnings
J&J's New Acquisition Strategy Makes Sense
Seeking Alpha
Friday, October 30, 2009 - 6:50am
tags:
JNJ, M&A, Elan, Crucell
Takeda Profit Jumps; Full-Year Sales Forecast Cut on Strong Yen
Bloomberg
Friday, October 30, 2009 - 6:49am
tags:
Teva Pharmaceuticals, earnings
Pay Attention To QLT
Investopedia
Friday, October 30, 2009 - 6:48am
tags:
QLT
U.S. FTC ok's Merck-Schering deal with conditions
Reuters
Thursday, October 29, 2009 - 5:00pm
tags:
FTC, Merck, Schering Plough, M&A
J&J Salesman Says He Sold Drug for Unapproved Uses
Bloomberg
Thursday, October 29, 2009 - 4:17pm
tags:
drug reps, off-label, JNJ, Risperdal
Cholesterol-lowering statin drugs like Lipitor, Zocor, may improve flu survival, study finds
Yahoo/AP
Thursday, October 29, 2009 - 4:15pm
tags:
Lipitor, Zocor, Flu, statins
In Vermont: a fierce debate over free drug samples
Times Argus, VT
Thursday, October 29, 2009 - 3:33pm
tags:
Vermont, samples, PhRMA, drug reps
How Pfizer Rewards Its Bosses for Eliminating Jobs
Minyanville
Thursday, October 29, 2009 - 3:29pm
tags:
Pfizer, layoffs, M&A, Wyeth
Swine flu vaccine boosts AstraZeneca quarterly earns, but investors cautious on outlook
Yahoo/AP
Thursday, October 29, 2009 - 3:25pm
tags:
AstraZeneca, earnings, vaccines, swine flu
Why The Market's Up, But Merck's Down
CNBC
Thursday, October 29, 2009 - 3:24pm
tags:
Merck, Abbott Laboratories, Schering Plough, Zetia

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.